← Back to Search

Peer-Delivered Behavioral Activation for Opioid Addiction (HEAL Together Trial)

N/A

Recruiting

Led By Jessica F Magidson, PhD

Research Sponsored by University of Maryland, College Park

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Minimum of 18 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up assessed between the baseline assessment and the final follow-up (approximately 6 months post-baseline)

Awards & highlights

HEAL Together Trial Summary

This trial is testing a new behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) among low-income, minority individuals living with opioid use disorder (OUD) in Baltimore, Maryland.

Who is the study for?

This trial is for adults over 18 in Baltimore with opioid use disorder who have started methadone treatment at the study site within the last three months or have had trouble sticking to their methadone regimen. It's not for those with untreated severe mental health issues, non-English speakers, or pregnant individuals.Check my eligibility

What is being tested?

The 'Peer Activate' program, led by peer recovery specialists using behavioral activation techniques, aims to improve how well participants stick to their medication-assisted treatment for opioid addiction compared to usual care. The effectiveness and implementation will be studied over six months.See study design

What are the potential side effects?

Since this intervention involves behavioral support rather than medication, there are no direct medical side effects. However, participants may experience emotional discomfort when discussing personal issues related to drug use.

HEAL Together Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am at least 18 years old.

HEAL Together Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ assessed between the baseline assessment and the final follow-up (approximately 6 months post-baseline)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~assessed between the baseline assessment and the final follow-up (approximately 6 months post-baseline)

This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed between the baseline assessment and the final follow-up (approximately 6 months post-baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Intervention Acceptability Measured by Intervention Attendance

Intervention Feasibility Measured by Intervention Initiation

Intervention Fidelity Measured by Independent Rating

+2 more

Other outcome measures

Change in depressive symptoms

Changes in substance use

HEAL Together Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Peer-Delivered Behavioral Activation ("Peer Activate")Experimental Treatment1 Intervention

Participants in the Peer Activate intervention will receive a PRS-delivered behavioral activation intervention to address barriers to retention in methadone treatment and increase substance-free, positive reinforcement to support retention.

Group II: Treatment As UsualActive Control1 Intervention

Participants in the TAU group will receive treatment as usual (weekly group and individual counseling with an addiction counselor in addition to referral to other available services in the community through study contact).

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Maryland, College ParkLead Sponsor

155 Previous Clinical Trials

45,465 Total Patients Enrolled

Henry Ford Health SystemOTHER

300 Previous Clinical Trials

2,099,682 Total Patients Enrolled

University of Maryland, BaltimoreOTHER

688 Previous Clinical Trials

374,456 Total Patients Enrolled

Media Library

Peer-Delivered Behavioral Activation Clinical Trial Eligibility Overview. Trial Name: NCT05299515 — N/A

Opioid Use Disorder Research Study Groups: Peer-Delivered Behavioral Activation ("Peer Activate"), Treatment As Usual

Opioid Use Disorder Clinical Trial 2023: Peer-Delivered Behavioral Activation Highlights & Side Effects. Trial Name: NCT05299515 — N/A

Peer-Delivered Behavioral Activation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05299515 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent are individuals involved in this clinical investigation?

"Affirmative. As per the information accessible on clinicaltrials.gov, this research is currently looking for participants and was initially posted on September 1st 2022. Furthermore, 200 people need to be recruited from 2 distinct medical centres."

Answered by AI

Is enrollment for this research endeavor currently taking place?

"Affirmative. Information available on clinicaltrials.gov attests that recruitment for this trial commenced on September 1st, 2022 and was last amended October 4th, 2022. Two medical centres are looking to enrol 200 participants in total."

Answered by AI